Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Class A Common Stock, $0.0001 par value per share
-
Shares outstanding
-
99,823,000
-
Number of holders
-
21
-
Total 13F shares, excl. options
-
1,240,919
-
Shares change
-
+41,618
-
Total reported value, excl. options
-
$20,288,000
-
Value change
-
+$544,186
-
Number of buys
-
14
-
Number of sells
-
5
-
Price
-
$16.35
Institutional Holders of Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) as of Q4 2021
As of 31 Dec 2021 Rani Therapeutics Holdings, Inc. - Class A Common Stock, $0.0001 par value per share (RANI) had 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 1,240,919 shares of stock of the company.
Largest 10 holders included Nan Fung Group Holdings Ltd, VANGUARD GROUP INC, BlackRock Inc., Alpha Square Group S, LLC, GEODE CAPITAL MANAGEMENT, LLC, Squarepoint Ops LLC, STIFEL FINANCIAL CORP, ADVISOR GROUP HOLDINGS, INC., STATE STREET CORP, and CAAS CAPITAL MANAGEMENT LP.
This table shows 21 institutional shareholders of the security as of 31 Dec 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.